Select Publications
Conference Papers
1993, 'PHASE-I STUDY OF REPEATED TREATMENT WITH CHIMERIC ANTI-CD4 MONOCLONAL-ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LIPPINCOTT-RAVEN PUBL, pp. A280 - A281, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1993KY35600489&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1992, 'PHASE-1 CLINICAL-TRIAL OF CHIMERIC MONOCLONAL ANTI-CD4 ANTIBODY IN MULTIPLE-SCLEROSIS', in NEUROLOGY, LITTLE BROWN CO, CA, SAN DIEGO, pp. 413 - 419, presented at 44th Annual Meeting of the American-Academy-of-Neurology, CA, SAN DIEGO, http://dx.doi.org/10.1212/WNL.44.3_Part_1.413
,Conference Proceedings (Editor of)
Wang CC; Li J; Tran GT; Hodgkinson SJ; Hall BM; Mccaughan GW; Allen R; Bishop GA, (eds.), 2005, 'Immunology and Cell Biology', Blackwell Publishing Asia, Carlton, Victoria, Australia, presented at 23rd Annual Scientific Meeting of the Transplantation Society of Australia and NZ, Canberra, 11 May 2005 - 13 May 2005
Conference Presentations
2018, 'Determinants of MS re-activation after discontinuing therapies', presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), GERMANY, Berlin, 10 October 2018 - 12 October 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000446861400464&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'PARADOXICAL REACTION IN TUBERCULOUS MENINGITIS: A TERTIARY REFERRAL HOSPITAL RETROSPECTIVE EXPERIENCE OF CONCOMITANT IMMUNOSUPPRESSION THERAPY', presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Darwin, 29 May 2018 - 01 June 2018, http://dx.doi.org/10.1136/jnnp-2018-ANZAN.17
,Conference Abstracts
2024, '#1167 Examination of subsets of CD4+ lymphocyte subpopulations in long-surviving renal transplant patients', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 39, http://dx.doi.org/10.1093/ndt/gfae069.1666
,2024, '#1896 Monitoring of peripheral blood B cell subsets in long-surviving renal transplant patients', in Nephrology Dialysis Transplantation, Oxford University Press (OUP), Vol. 39, http://dx.doi.org/10.1093/ndt/gfae069.952
,2023, 'Disability accrual in primary and secondary progressive multiple sclerosis', in Journal of Neurology, Neurosurgery and Psychiatry, Vol. 94, pp. 707 - 717, http://dx.doi.org/10.1136/jnnp-2022-330726
,2020, 'Phase i study of ata188, an off-the-shelf, allogeneic epstein-barr virus-targeted t-cell immunotherapy for progressive forms of multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 228 - 228, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100451&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Pregnancy in a modern day multiple sclerosis cohort: predictors of postpartum relapse and disability progression', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 652 - 653, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Real-world experience with ocrelizumab in the msbase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 550 - 551, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547102002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Switching from ocrelizumab to cladribine: real world data', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 67 - 68, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'The effect of cladribine upon naive and activated cd4(+) t regulatory cells in ms patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ELECTR NETWORK, Vol. 26, pp. 314 - 314, presented at 8th Joint ACTRIMS-ECTRIMS Meeting (MSVirtual), ELECTR NETWORK, 11 September 2020 - 13 September 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000596547101180&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Cladribine: a multicentre LOng-term efficacy Biomarker Australian Study (CLOBAS)', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Predicting Long-Term Sustained Disability Progression in Multiple Sclerosis', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058004051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Real-world experience of oral cladribine use in the MSBase Registry', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058006063&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, 'Short term efficacy and safety outcomes after switching from Anti-CD20 DMTs to Cladribine in a real-world setting', in NEUROLOGY, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Toronto, Vol. 94, presented at Annual Meeting of the American-Academy-of-Neurology, CANADA, Toronto, 25 April 2020 - 01 May 2020, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000536058009171&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Cladribine: a multicentre Long-term efficacy Biomarker Australian Study (CLOBAS)', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP63, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300075&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Clinical experience with cladribine in patients with relapsing-remitting multiple sclerosis', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP64 - NP65, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300077&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Real world experience with Cladribine (Mavenclad) in MSBase registry', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SINGAPORE, Singapore, Vol. 26, pp. NP63 - NP64, presented at Conference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), SINGAPORE, Singapore, 13 November 2019 - 15 November 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000556862300076&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Multiple sclerosis associated with increased activated CD4+CD25+Foxp3+T regulatory cells but reduced Th17 associated regulatory cells', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, SWEDEN, Stockholm, Vol. 25, pp. 918 - 918, presented at 35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, SWEDEN, Stockholm, 11 September 2019 - 13 September 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485303104036&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, '"Code stroke" in the 24-hour time window from stroke onset: burden on hospital resources', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 14, pp. 9 - 9, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000485243200034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Cryptogenic stroke is linked to cardioembolic aetiology: a histopathological study of thrombus retrieved after endovascular thrombectomy', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 20 - 20, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Erythrocyte-rich clots are associated with cardioembolic aetiology, reduced number of manoeuvres, and improved clinical outcome in acute ischemic stroke patients', in EUROPEAN JOURNAL OF NEUROLOGY, WILEY, NORWAY, Oslo, Vol. 26, pp. 180 - 180, presented at 5th Congress of the European-Academy-of-Neurology (EAN), NORWAY, Oslo, 29 June 2019 - 02 July 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000474481000283&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'CLADRIBINE: A MULTICENTRE LONG-TERM EFFICACY BIOMARKER AUSTRALIAN STUDY (CLOBAS)', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Sydney, Vol. 90, presented at Annual Scientific Meeting of the Australian-and-New Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Sydney, 21 May 2019 - 24 May 2019, http://dx.doi.org/10.1136/jnnp-2019-anzan.119
,2019, 'Activation of naive CD4(+)CD25(+)FOXP3(+)Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500434&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Recently alloactivated CD4(+)CD8(-)CD25(+)T regulatory cells express CD8alpha and are potent suppressor cells', in JOURNAL OF IMMUNOLOGY, AMER ASSOC IMMUNOLOGISTS, CA, San Diego, Vol. 202, presented at 103rd Annual Meeting of the American-Association-of-Immunologists, CA, San Diego, 09 May 2019 - 13 May 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000524982500109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2019, 'Activation of naive CD4+CD25+FOXP3+Treg by specific autoantigen and Th2 cytokines IL-4 and IL-5 induces autoantigen specific Treg that inhibit EAE', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 116.16 - 116.16, http://dx.doi.org/10.4049/jimmunol.202.supp.116.16
,2019, 'Recently alloactivated CD4+CD8−CD25+T regulatory cells express CD8alpha and are potent suppressor cells', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 57.20 - 57.20, http://dx.doi.org/10.4049/jimmunol.202.supp.57.20
,2019, 'Th2 cytokines and specific donor alloantigen activated CD4+CD25+T cells reverse chronic rejection: role of IL-4 and IL-5 in promoting antigen-specific Treg', in The Journal of Immunology, The American Association of Immunologists, Vol. 202, pp. 186.11 - 186.11, http://dx.doi.org/10.4049/jimmunol.202.supp.186.11
,2019, 'Non-Contrast Computed Tomography Based Patient Selection Achieves Similar Outcomes to Advanced Neuroimaging in Late Time Window Endovascular Thrombectomy', in STROKE, LIPPINCOTT WILLIAMS & WILKINS, HI, Honolulu, Vol. 50, presented at American-Heart-Association/American-Stroke-Association International Stroke Conference / State-of-the-Science Stroke Nursing Symposium, HI, Honolulu, 06 February 2019 - 08 February 2019, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000478733400150&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Factors associated with delayed hospital presentation for acute stroke events in South Western Sydney', in INTERNATIONAL JOURNAL OF STROKE, SAGE PUBLICATIONS LTD, Vol. 13, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000440952200111&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Alloactivation of Human CD4+CD25+CD127loCD45RA-Fox3hi Treg Population to Induce Potential Alloantigen Specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, SPAIN, Madrid, Vol. 102, pp. S145 - S145, presented at 27th International Congress of the Transplantation-Society (TTS), SPAIN, Madrid, 30 June 2018 - 05 July 2018, http://dx.doi.org/10.1097/01.tp.0000542769.25232.5b
,2018, 'Activation of Human Naive T Regulatory Cells for MS Therapy By Stimulation with Antigen and Interleukin-4', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 89 - 89, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600198&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Phenotypic Analysis of T Regulatory Cells in Multiple Sclerosis Patients', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, CA, San Diego, Vol. 24, pp. 93 - 94, presented at ACTRIMS Forum, CA, San Diego, 01 February 2018 - 03 February 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000429034600207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Response to Immunosuppressive Therapy in Cerebral Amyloid Angiopathy-related Inflammation', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, AUSTRALIA, Sydney, Vol. 25, pp. 492 - 492, presented at Congress of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), AUSTRALIA, Sydney, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000460691800161&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'CD8 Expression Increases Suppressive Ability of CD4+CD25+Treg and is a Marker of Antigen-Specificity', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S37 - S37, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520351.47820.c8
,2017, 'Human CD4+CD25+CD127loFOXP3+Treg Activation by IL-4 and Alloantigen Induces Activated Treg that do not Express CD45RA and Express the IL-5 Receptor Alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S7 - S7, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520300.20897.2c
,2017, 'Interleukin 5 (IL-5) Treatment Prevents Chronic Allograft Rejection by Promoting IL-5 Receptor Expressing CD4+CD25+T Regulatory Ts2 Cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, CANADA, Victoria, Vol. 101, pp. S43 - S43, presented at 15th Transplantation Science Symposium (TSS) of the Transplantation-Society, CANADA, Victoria, 24 May 2017 - 26 May 2017, http://dx.doi.org/10.1097/01.tp.0000520363.08810.76
,2017, 'TIMING OF HIGH-EFFICACY DISEASE MODIFYING THERAPIES FOR RELAPSING-REMITTING MULTIPLE SCLEROSIS', in JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, BMJ PUBLISHING GROUP, AUSTRALIA, Gold Coast, Vol. 88, presented at Annual Scientific Meeting of the Australian-and-New-Zealand-Association-of-Neurologists (ANZAN), AUSTRALIA, Gold Coast, 09 May 2017 - 12 May 2017, http://dx.doi.org/10.1136/jnnp-2017-316074.16
,2017, 'Contribution of different relapse phenotypes to disability in multiple sclerosis', in Multiple Sclerosis, Vol. 23, pp. 266 - 276, http://dx.doi.org/10.1177/1352458516643392
,2016, 'Australian cladribine experience', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 289 - 290, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201360&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Comparison of 5-year treatment outcomes between alemtuzumab versus natalizumab, fingolimod and interferon beta-1a', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 829 - 832, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267203257&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Individual response to disease modifying therapies: a global observational cohort study', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 358 - 360, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201468&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'MSFIRST - utilising a longitudinal, prospective, comparative drug safety module for use in everyday MS clinical practice to evaluate and track incidence and characteristics of safety outcomes in MS patients on therapy over the long term', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 342 - 343, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201443&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Pregnancy protects against long-term disability accrual in relapsing-remitting MS', in MULTIPLE SCLEROSIS JOURNAL, SAGE PUBLICATIONS LTD, ENGLAND, London, Vol. 22, pp. 120 - 122, presented at 32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), ENGLAND, London, 14 September 2016 - 17 September 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267201062&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Activation of Human CD4+CD25+CD127loFOXP3+Treg by IL-4 and alloantigen induces activated Treg that do not express CD45RA and express the IL-5 receptor alpha (CD125)', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S460 - S460, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953201100&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Interleukin-5 therapy prevents chronic allograft rejection by induction of antigen specific CD4+CD25+T regulatory cells', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S65 - S65, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200108&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'Recently alloactivated CD4+CD8-CD25+Treg express CD8 and are the antigen-specific Treg', in TRANSPLANTATION, LIPPINCOTT WILLIAMS & WILKINS, Vol. 100, pp. S120 - S120, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000436953200190&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'In Vitro Reactivity of CD4(+) T Cells Subsets from Hosts with Antigen Specific Transplant Tolerance Mediated by CD4(+)CD25(+) T Cells', in AMERICAN JOURNAL OF TRANSPLANTATION, WILEY-BLACKWELL, MA, Boston, Vol. 16, pp. 512 - 512, presented at American Transplant Congress, MA, Boston, 11 June 2016 - 15 June 2016, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383373903337&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,